Key Takeaways
- • US venture deal value reached $515.8 billion across roughly 14,199 deals through 30 September 2026, already about 44% above the $357.9 billion recorded for all of 2021, with AI companies taking 82.7% of the money, according to the Q3 2026 PitchBook-NVCA Venture Monitor.
- • The term sheet fixes the economics and control of a venture round, covering valuation, liquidation preference, anti-dilution, pro rata rights, board seats and protective provisions.
- • Standard terms remained investor-friendly but not aggressive in Q2 2026: 95.8% of deals tracked by Cooley used a 1x liquidation preference and 96.4% used non-participating preferred stock.
- • Gunderson Dettmer ranked as the most active venture law firm worldwide in Q2 2026 with 290 global deals worth $96 billion, while Cooley ranked first for representing companies raising venture capital, per firm announcements.
Summary
This explainer outlines how venture capital works, the funding stages companies move through, and the legal documentation behind each round. A venture firm raises a fund from limited partners such as pension funds, endowments, family offices and corporates, then invests through general partners in private companies over several years. Returns depend on a few large wins offsetting many losses, and the firm is typically paid a management fee plus carried interest. In exchange for capital, investors receive preferred shares with rights that founders and employees do not hold.
The article cites the Q3 2026 PitchBook-NVCA Venture Monitor for US venture activity. Deal value reached $515.8 billion through 30 September 2026, with most of it coming from a handful of large AI rounds in the first half. Third-quarter deal value fell to $98.4 billion across about 5,012 deals, and US VC funds raised $108.5 billion across 699 funds. Invest Europe's preliminary data showed a record €11.5 billion of European VC investment in H1 2026, up 11% year on year. Cooley's Q2 2026 data put the median Series B pre-money valuation at $185.2 million, up from $152.5 million in Q1.
The article maps the typical stages from pre-seed and seed, usually funded by SAFEs, convertible notes or UK advance subscription agreements, through priced Series A preferred rounds, Series B and C rounds, and late-stage or growth financings that may include secondaries and venture debt. For term sheets, Cooley's Q2 2026 report, covering 166 financings, found 83.6% up rounds, 4.3% flat and 12.1% down. Pay-to-play provisions appeared in 8.4% of deals and redemption rights in 5.4%. Anti-dilution was not reported in Cooley's summary, though broad-based weighted average is described as the market norm.
US rounds typically draw on NVCA model documents, whose October 2025 update added mechanics for tranched financings. In the UK, the equivalent set is published by UK Private Capital, formerly the British Private Equity & Venture Capital Association (BVCA), which changed its name in January 2026. Venture lawyers act for company, investor or fund counsel. On league tables, the article notes that PitchBook's own pages could not be accessed, so rankings rely on firm announcements: Gunderson Dettmer (Q2 2026), Cooley (company-side work for more than six years) and Orrick (third globally and first in Europe for Q1 2026).
The article cites the Q3 2026 PitchBook-NVCA Venture Monitor for US venture activity. Deal value reached $515.8 billion through 30 September 2026, with most of it coming from a handful of large AI rounds in the first half. Third-quarter deal value fell to $98.4 billion across about 5,012 deals, and US VC funds raised $108.5 billion across 699 funds. Invest Europe's preliminary data showed a record €11.5 billion of European VC investment in H1 2026, up 11% year on year. Cooley's Q2 2026 data put the median Series B pre-money valuation at $185.2 million, up from $152.5 million in Q1.
The article maps the typical stages from pre-seed and seed, usually funded by SAFEs, convertible notes or UK advance subscription agreements, through priced Series A preferred rounds, Series B and C rounds, and late-stage or growth financings that may include secondaries and venture debt. For term sheets, Cooley's Q2 2026 report, covering 166 financings, found 83.6% up rounds, 4.3% flat and 12.1% down. Pay-to-play provisions appeared in 8.4% of deals and redemption rights in 5.4%. Anti-dilution was not reported in Cooley's summary, though broad-based weighted average is described as the market norm.
US rounds typically draw on NVCA model documents, whose October 2025 update added mechanics for tranched financings. In the UK, the equivalent set is published by UK Private Capital, formerly the British Private Equity & Venture Capital Association (BVCA), which changed its name in January 2026. Venture lawyers act for company, investor or fund counsel. On league tables, the article notes that PitchBook's own pages could not be accessed, so rankings rely on firm announcements: Gunderson Dettmer (Q2 2026), Cooley (company-side work for more than six years) and Orrick (third globally and first in Europe for Q1 2026).
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.